Acrisure Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,398	Closed	-$243K	–	159
2023 Q1	$243K	Buy	+2,398	New	+$243K	0.25%	187